Approval · Notice of Compliance 24419 · 2020
TWYNSTA: Notice of Compliance 24419
Issued October 9, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24419
- Date
- October 9, 2020
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety updates to align the Product Monograph with the Reference Product for amlodipine besylate, NORVASC
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TWYNSTA | Not yet assigned | — |
Medicinal ingredients
- AMLODIPINE BESYLATE 5 MG per TAB
- TELMISARTAN 40 MG per TAB
- AMLODIPINE BESYLATE 10 MG per TAB
- TELMISARTAN 80 MG per TAB